decreased circulating vldl cholesterol level Gene Set

Dataset MPO Gene-Phenotype Associations
Category disease or phenotype associations
Type phenotype
Description reduced amount in the blood of the lipoprotein:cholesterol complex that transports triglycerides from the intestine and liver to muscle and adipose tissue (Mammalian Phenotype Ontology, MP_0005146)
External Link
Similar Terms
Downloads & Tools


22 gene mutations causing the decreased circulating vldl cholesterol level phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

Symbol Name
ADIPOR2 adiponectin receptor 2
ANGPTL3 angiopoietin-like 3
ANGPTL4 angiopoietin-like 4
APOA1 apolipoprotein A-I
APOB apolipoprotein B
APOC3 apolipoprotein C-III
APOE apolipoprotein E
CES1 carboxylesterase 1
GHR growth hormone receptor
LCAT lecithin-cholesterol acyltransferase
LPIN1 lipin 1
MALRD1 MAM and LDL receptor class A domain containing 1
MGAT4B mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B
MIR122 microRNA 122
MOGAT2 monoacylglycerol O-acyltransferase 2
MTTP microsomal triglyceride transfer protein
NR0B2 nuclear receptor subfamily 0, group B, member 2
PON2 paraoxonase 2
PRKAR2B protein kinase, cAMP-dependent, regulatory, type II, beta
SEC14L2 SEC14-like 2 (S. cerevisiae)
SOAT2 sterol O-acyltransferase 2
TLR2 toll-like receptor 2